The Risks of miRNA Therapeutics: In a Drug Target Perspective.

Zhang, Song; Cheng, Zhujun; Wang, Yanan; Han, Tianyu

Zhang, Song; Cheng, Zhujun; Wang, Yanan; Han, Tianyu.

Afiliación

Zhang S; Jiangxi Institute of Respiratory Disease, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, People's Republic of China.
Cheng Z; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, People's Republic of China.
Wang Y; Department of Burn, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, People's Republic of China.
Han T; Jiangxi Institute of Respiratory Disease, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, People's Republic of China.

Drug Des Devel Ther ; 15: 721-733, 2021.

Article en En | MEDLINE | ID: mdl-33654378

Asunto(s)

MicroARNs/efectos adversos; Humanos; MicroARNs/uso terapéutico; Factores de Riesgo

Palabras clave

RNAi; miRNA; siRNA; therapeutics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: MicroARNs Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Drug Des Devel Ther Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google